BAXTER INTERNATIONAL INC (BAX) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for BAXTER INTERNATIONAL INC?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, BAXTER INTERNATIONAL INC's filing signal
continuing negative.
earningsVibe SuperAnalyst™ Verdict:
CONTINUING NEGATIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-8.67%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Continuing Negative
CLAUDE
Turned Negative
CHATGPT
Continuing Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does BAXTER INTERNATIONAL INC actually do?
Answer:
Baxter International Inc. is a global medical technology company that develops, manufactures, and sells a wide array of essential healthcare products, digital health solutions, and therapies. Its offerings include sterile intravenous (IV) solutions, infusion systems, parenteral nutrition, inhaled anesthetics, injectable pharmaceuticals, surgical sealants, smart bed systems, patient monitoring technologies, and respiratory health devices. These products serve hospitals, nursing homes, doctors' offices, and home-based patients in over 100 countries. Following the divestiture of its Kidney Care business in January 2025 and its BioPharma Solutions business in September 2023, Baxter now operates through three primary segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. The company's strategy focuses on driving sustainable growth through innovation, portfolio optimization, and operational simplification.
Question:
What are BAXTER INTERNATIONAL INC's revenue drivers?
Answer:
Revenue is primarily driven by the sale of sterile IV solutions, infusion systems, parenteral nutrition, surgical hemostats and sealants, smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and specialty injectable pharmaceuticals and inhaled anesthetics.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required